Headquarters
1452 HUGHES RD STE 200, GRAPEVINE, TX 76051-9221, US
GRAPEVINE, TX, US
ALPHA COGNITION USA, INC.
From the company
Alpha Cognition is a commercial stage biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The company received FDA approval on July 26, 2024 of its New Drug Application for ZUNVEYL (benzgalantamine), previously known as ALPHA-1062 oral tablet formulation, for the treatment of mild-to-moderate Alzheimer's disease.
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.